Stock Analysis

EuroGroup Laminations Second Quarter 2024 Earnings: EPS: €0.046 (vs €0.058 in 2Q 2023)

BIT:EGLA
Source: Shutterstock

EuroGroup Laminations (BIT:EGLA) Second Quarter 2024 Results

Key Financial Results

  • Revenue: €219.3m (down 2.7% from 2Q 2023).
  • Net income: €7.91m (down 12% from 2Q 2023).
  • Profit margin: 3.6% (down from 4.0% in 2Q 2023). The decrease in margin was driven by lower revenue.
  • EPS: €0.046 (down from €0.058 in 2Q 2023).
earnings-and-revenue-growth
BIT:EGLA Earnings and Revenue Growth August 5th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

EuroGroup Laminations Earnings Insights

Looking ahead, revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 9.7% growth forecast for the Electrical industry in Italy.

Performance of the Italian Electrical industry.

The company's shares are up 2.0% from a week ago.

Balance Sheet Analysis

While earnings are important, another area to consider is the balance sheet. We have a graphic representation of EuroGroup Laminations' balance sheet and an in-depth analysis of the company's financial position.

Valuation is complex, but we're here to simplify it.

Discover if EuroGroup Laminations might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.